Valneva SE (VALN) Dividends Paid - Common (2021 - 2026)
Valneva SE (VALN) posted Dividends Paid - Common of $123.2 million for Q1 2026, up 690.74% sequentially from -$20.9 million in Q3 2025, and down 23.42% YoY from $160.9 million in Q1 2025.
Valneva SE (VALN) Dividends Paid - Common (2021 - 2026) Analysis & Trends
Valneva SE has reported Dividends Paid - Common for 6 years, with the latest figure at $123.2 million in Q1 2026.
- Quarterly Dividends Paid - Common fell 23.42% year-over-year to $123.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $272.7 million (up 79.01% YoY) and the FY2024 annual result came in at $182.1 million, up 33.54% from the prior year.
- Dividends Paid - Common advanced to $123.2 million in Q1 2026 per VALN's latest filing, from -$20.9 million in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $222.3 billion in Q2 2023 and troughed at -$222.3 billion in Q3 2023.
- A 5-year average of $61.5 million and a median of $26.3 million in 2022 frame the typical range for Dividends Paid - Common.
- The widest YoY moves for Dividends Paid - Common: up 834563.64% in 2023, down 293196.2% in 2023.
- Over 5 years, Dividends Paid - Common stood at $26.0 million in 2022, then sank by 286.89% to -$48.6 million in 2023, then soared by 126.24% to $12.8 million in 2024, then tumbled by 263.56% to -$20.9 million in 2025, then surged by 690.74% to $123.2 million in 2026.
- According to Business Quant data, Dividends Paid - Common over the past three periods registered $123.2 million, -$20.9 million, and $9.4 million for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 34.60 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Valneva SE | 618.67 Mn | 477.41 Mn | 1.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 123.24 Mn |
| Mar 31, 2026 | 123.24 Mn |
| Sep 30, 2025 | -20.86 Mn |
| Sep 30, 2025 | -20.86 Mn |
| Jun 30, 2025 | 9.41 Mn |
| Jun 30, 2025 | 9.41 Mn |
| Mar 31, 2025 | 160.93 Mn |
| Mar 31, 2025 | 160.93 Mn |
| Dec 31, 2024 | 12.75 Mn |
| Dec 31, 2024 | 12.75 Mn |
| Sep 30, 2024 | 27.37 Mn |
| Sep 30, 2024 | 27.37 Mn |
| Jun 30, 2024 | -48.70 Mn |
| Jun 30, 2024 | -48.70 Mn |
| Mar 31, 2024 | 191.89 Mn |
| Mar 31, 2024 | 191.89 Mn |
| Dec 31, 2023 | -48.60 Mn |
| Dec 31, 2023 | -48.60 Mn |
| Sep 30, 2023 | -222.33 Bn |
| Sep 30, 2023 | -222.33 Bn |